UiPath slides as new price-target cuts revive worries over AI monetization timeline

PATHPATH

UiPath shares are down about 3% to $10.27 as investors react to fresh Wall Street price-target cuts that cite cautious outlook and uncertainty around near-term AI monetization. Recent analyst actions have lowered targets into the low-to-mid teens while maintaining mostly neutral/hold stances.

1. What’s moving the stock

UiPath (PATH) is trading lower today, extending a pullback that has been driven by Wall Street’s reset of expectations after the company’s cautious forward outlook. The latest pressure is tied to additional price-target reductions (including a cut to $13 from $17 while keeping a Neutral stance), which reinforce the view that upside depends on clearer proof that new AI/agentic automation products translate into accelerating ARR and durable growth. (tipranks.com)

2. Why the market is sensitive right now

UiPath recently posted a quarter with revenue around $481 million (up roughly 14% year over year) and highlighted its first full-year GAAP profitability, alongside a $500 million repurchase authorization—fundamentals that were broadly constructive. Even so, investors have stayed focused on the company’s cautious fiscal 2027 setup, which triggered multiple firms to trim price targets and kept sentiment fragile, making incremental negative analyst actions more impactful on down days. (finance.yahoo.com)

3. What to watch next

Near-term trading will likely hinge on whether management can demonstrate improving net-new ARR and tangible AI monetization, rather than product announcements alone. Investors will also monitor continued analyst revisions and any incremental signals from filings and positioning that could change the narrative from ‘proof required’ to ‘traction visible.’ (247wallst.com)